Dimensional Fund Advisors LP Has $500.60 Million Position in Danaher Corporation $DHR

by · The Cerbat Gem

Dimensional Fund Advisors LP lowered its stake in Danaher Corporation (NYSE:DHR – Free Report) by 2.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,526,634 shares of the conglomerate’s stock after selling 73,604 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.36% of Danaher worth $500,596,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of DHR. White Pine Capital LLC lifted its holdings in Danaher by 1.4% during the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock valued at $690,000 after purchasing an additional 49 shares during the last quarter. SOL Capital Management CO raised its position in shares of Danaher by 2.8% in the third quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock valued at $363,000 after purchasing an additional 50 shares during the period. Purkiss Capital Advisors LLC lifted its stake in shares of Danaher by 3.9% during the 3rd quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate’s stock worth $263,000 after buying an additional 50 shares during the last quarter. TCTC Holdings LLC boosted its holdings in shares of Danaher by 0.7% during the 3rd quarter. TCTC Holdings LLC now owns 7,439 shares of the conglomerate’s stock worth $1,475,000 after buying an additional 51 shares during the period. Finally, Howard Capital Management Group LLC grew its stake in Danaher by 4.8% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock valued at $230,000 after buying an additional 53 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Up 0.4%

Shares of Danaher stock opened at $204.74 on Thursday. The firm has a market capitalization of $144.78 billion, a PE ratio of 40.62, a price-to-earnings-growth ratio of 2.76 and a beta of 0.93. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. The firm’s 50 day moving average is $223.81 and its 200 day moving average is $216.12. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $242.80.

Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The company had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter last year, the business posted $2.14 EPS. Equities research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. This is a boost from Danaher’s previous quarterly dividend of $0.32. Danaher’s payout ratio is currently 25.40%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. HSBC lifted their price target on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a report on Monday, December 1st. Jefferies Financial Group boosted their target price on shares of Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. TD Cowen restated a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. KeyCorp reiterated an “overweight” rating on shares of Danaher in a research note on Thursday, January 29th. Finally, Morgan Stanley initiated coverage on shares of Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 target price on the stock. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $253.86.

View Our Latest Research Report on DHR

Insider Transactions at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares in the company, valued at $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 11.10% of the company’s stock.

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).